Gene Therapy for Cardiovascular Disease

Item

http://www.wikidata.org/entity/Q24791063

description

2003 nî lūn-bûn

@nan

2003 թուականին հրատարակուած գիտական յօդուած

@hyw

2003 թվականին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Gene Therapy for Cardiovascular Disease

@ast

Gene Therapy for Cardiovascular Disease

@en

Gene Therapy for Cardiovascular Disease

@nl

type

Item

label

Gene Therapy for Cardiovascular Disease

@ast

Gene Therapy for Cardiovascular Disease

@en

Gene Therapy for Cardiovascular Disease

@nl

prefLabel

Gene Therapy for Cardiovascular Disease

@ast

Gene Therapy for Cardiovascular Disease

@en

Gene Therapy for Cardiovascular Disease

@nl

P1476

Gene Therapy for Cardiovascular Disease

@en

P2093

Andrew H. Baker

http://www.w3.org/2001/XMLSchema#string

Kate L. Dishart

http://www.w3.org/2001/XMLSchema#string

Laura Denby

http://www.w3.org/2001/XMLSchema#string

Lorraine M. Work

http://www.w3.org/2001/XMLSchema#string

P2860

Site-specific integration by adeno-associated virus

Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination

Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein.

Systemic gene therapy for cardiovascular disease.

Cardiovascular gene therapy.

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Gene therapy for restenosis.

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

P304

138-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/S1110724303209086

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2003

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12721517

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

cardiovascular disease

P932

323957

http://www.w3.org/2001/XMLSchema#string